Therapy
Pharmaceutical
Health

Albireo Pharma

$28.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (0.24%) As of 2:23 PM EDT today
+$0.07 (0.24%) Today

Why Robinhood?

You can buy or sell Albireo Pharma and other stocks, options, ETFs, and crypto commission-free!

About ALBO

Albireo Pharma, Inc. Common Stock, also called Albireo Pharma, is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Read More Its product pipeline includes A4250, Elobixibat, and A3384. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Employees
39
Headquarters
Boston, Massachusetts
Founded
2003
Market Cap
347.20M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
47.25K
High Today
$29.28
Low Today
$28.68
Open Price
$28.90
Volume
21.37K
52 Week High
$38.69
52 Week Low
$19.10

Collections

Therapy
Pharmaceutical
Health

ALBO News

Yahoo FinanceJun 20

Those Who Purchased Albireo Pharma Shares A Year Ago Have A 11% Loss To Show For It

57
Yahoo FinanceJun 20

Albireo Announces Launch of “PFIC Voices”

9

ALBO Earnings

-$1.39
-$0.34
$0.72
$1.77
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market

More ALBO News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.